《大行》花旗升荣昌生物(09995.HK)目标价至35元 销售符合预期

阿斯达克财经
Aug 26, 2025

花旗发表报告指,荣昌生物(09995.HK) 上半年收入为11亿元人民币(下同),按年增长48%。净亏损4.5亿元,相比2024年上半年净亏损7.8亿元。销售费用比率从2024年上半年的53%下降至2025年上半年的48%。研发费用下降20%至6.47亿元。截至今年6月底,公司持有现金及现金等价物约13亿元。管理层目标是2025年将亏损缩减50%,并在2026年实现盈亏平衡。该行更新预测,2025...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10